Adverum Biotechnologies Executives Buy Shares Amidst Recent Volatility.

lunes, 8 de diciembre de 2025, 10:35 pm ET1 min de lectura
ADVM--

Adverum Biotechnologies, Inc. (ADVM) recently announced that Director, CEO, and President Laurent Fischer acquired 11,085 shares at $4.24 per share on December 5, 2025, and an additional 117,614 shares at $4.31 per share on December 8, 2025. Meanwhile, Chief Operating Officer Peter Soparkar purchased 50,000 shares at $4.22 per share on December 5, 2025.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios